Biologics share of pharmaceutical market in Canada by payer 2018
In 2018, payments from public plans drug costs for biologics amounted for 27.3 percent of the total Canadian pharmaceutical market. The statistic illustrates the biologics share of the pharmaceutical market in Canada in 2018, by payer type.